Following mucormycosis (black-fungus), four Covid-recovered patients in Pune have been diagnosed with another fungal infection in the last three months, raising worries within the medical community. It is difficult to identify aspergillus-osteomyelitis because it mimics spinal tuberculosis. However, a similar infection has been witnessed among the Covid-recovered individuals. Long-term corticosteroid usage may raise the risk of infections,… read-more
Courtesy: The Times of India
Following the cases of black fungus (Mucormycosis) among the post-COVID-19 patients, three patients have been found suffering from Avascular necrosis or death of bones tissues in Mumbai. The patients, who are also doctors, after experiencing pain in their femur bone, rushed for treatment. “In patients who have suffered from long Covid-19 and needed steroids, this is a worry,” said a civic hospital doctor.
Courtesy: The Times of India
After losing both eyes to black fungus (Mucormycosis), a 46-year-old policeman allegedly shot himself with his service pistol in Maharashtra's Nagpur city on July 3. According to the police officials, head constable Pramod Mergurwar contracted black fungus following the recovery from COVID-19. However, Mergurwar lost both his eyes during the treatment of fungus infection. Besides, he is survived by his wife and two children.
Courtesy: India Today
The world’s first patient of 'Optic Neuritis' from black fungus is found in UP's Kanpur. Ashish, a 30-year-old was suffering from it since the last 15 days, and is admitted to 'Hallett Hospital'. Asked about effects, the doctors said the nerves of the eyes become inflamed due to which it may stop sending messages to brain or occur in lost vision. Besides the treatment, a research has also been initiated.
Courtesy: Zee News
The Delhi Police Crime Branch unearthed 3,293 vials of fake black fungus injections from Dr. Altamas Hussain's house in southeast Delhi. A gang of ten people, including two doctors were arrested. Several expired drug were found, used for the treatment of black fungus along with 'Remdesivir' injections, said Monika Bhardwaj, DCP, Crime Branch. Reportedly, they sold 400 injections charging up to Rs 12,000 per bottle.
DentalDost, founded by Bhanushali and Rajat Kabade, enables those at home to assess their oral health using a 24/7 helpline and an app. The software uses imaging, quizzes, and instructions which allow individuals to examine their oral cavity from teeth and gums to the palate, and check for various disorders including Black Fungus. DentalDost is said to be receiving over eight suspected cases of Black Fungus every week.
The GST Council meeting scheduled on June 12 will be chaired by FinMin Nirmala Sitharaman. Reportedly, GST rate cut on COVID essentials and Black Fungus medicines will be discussed with the ‘Council’ formed in May 28 GST meeting including state ministers and a Group of Ministers to discuss on COVID essentials. The GoM on June 7 submitted its report recommending tax cuts to ease the burden on patients.
Courtesy: The Hindu
Karnataka has registered its first case of Mucormycosis (black fungus) in children. The disease has been detected in two children, aged 11 and 14, in Ballari district and Chitradurga district of the state. The children have been admitted to government hospitals and are currently in critical condition. As of now, Karnataka has reported 1250 cases of black fungus, of which at least 39 people have succumbed to the deadly disease.
Courtesy: Times Now
Haryana CM Manohar Lal Khattar on May 30 revealed that 750 mucormycosis patients have been identified in the state with 50 deaths, 50 recoveries and 650 patients undergoing treatment. In the virtual news conference, CM assured of procuring the injection used in treating mucormycosis. Earlier, directing the officials to instil more beds in hospitals, Health Minister Anil Vij said requisition of 12,000 Amphotericin-B injections has been made to… read-more
Giving relief amidst mounting Mucormycosis cases, Bajaj Healthcare on May 28 launched a drug to treat the black fungus infection in the COVID-19 patients. Named Posaconazole API, the anti-fungal drug has been granted regulatory approval by the Food and Drugs Administration (FDA) Gandhinagar, Gujarat. Meanwhile, the company aims at starting commercial production as early as in June first week for the both domestic and international market.